RBP4 and COVID-19: In our study, we demonstrated significantly reduced RBP4 (p < 0.01) and vitamin A levels (p < 0.001) in the group of hospitalized COVID-19 patients in the acute phase of COVID-19 infection compared to convalescent patients after a mild course.